Virtual screening of phenylsulfonamido-3-morpholinopropan-2-yl dihydrogen phosphate derivatives as novel inhibitors of MurC-MurF ligases from Mycobacterium leprae

Medicinal Chemistry Research

Volumn 21, Issue 12, 2012, Pages

  Shanmugam, Anusuya ^a   Anbazhagan, Venkattappan ^a   Natarajan, Jeyakumar ^b  

^a Vinayaka Missions University   (India)

^b BHARATHIAR UNIVERSITY   (India)

Author keywords

Multi drug resistance; Multiple inhibitor; Mur ligases; Peptidoglycan; Virtual screening

Indexed keywords

1 (3 ACETYL PHENYL SULFONAMIDE) 3 MORPHOLINO PROPAN 2 YL DIHYDROGEN PHOSPHATE; BACTERIAL ENZYME; LIGASE INHIBITOR; MURC LIGASE; MURD LIGASE; MURE LIGASE; MURF LIGASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG SCREENING; ENZYME BINDING; ENZYME INHIBITION; HYDROGEN BOND; MYCOBACTERIUM LEPRAE; VIRTUAL REALITY;

EID: 84885387015     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9958-9     Document Type: Article

References (31)

1. Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, Blanot D (2008) Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol Rev 32:168-207
2. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235-242
3. Dharmshaktu NS, Barkakaty BN, Patnaik PK, Arif MA (1999) Progress towards elimination of leprosy as a public health problem in India and role of modified leprosy elimination campaign. Lepr Rev 70:430-439
4. El Zoeiby A, Sanschagrin F, Levesque RC (2003) Structure and function of the Mur enzymes: development of novel inhibitors. Mol Microbiol 47:1-12
5. Gegnas LD, Waddell ST, Chabin RM, Reddy S, Wong KK (1998) Inhibitors of the bacterial cell wall biosynthesis enzyme Mur D. Bioorg Med Chem Lett 8:1643-1648
6. Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17:490-519
7. Humljan J, Kotnik M, Boniface A, Solmajer T, Urleb U, Blanot D, Gobec S (2006) A new approach towards peptidosulfonamides: synthesis of potential inhibitors of bacterial peptidoglycan biosynthesis enzymes MurD and MurE. Tetrahedron 62:10980-10988
8. Humljan J, Kotnik M, Contreras-Martel C, Blanot D, Urleb U, Dessen A, Solmajer T, Gobec S (2008) Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme. J Med Chem 51:7486-7494
9. Jorgensen WL, Tirado-Rives J (1988) The OPLS force field for proteins. Energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 110:1657-1666
10. Jovetic S, Zhu Y, Marcone GL, Marinelli F, Tramper J (2010) b-Lactam and glycopeptide antibiotics: first and last line of defense? Trends Biotechnol 28:596-604
11. Kotnik M, Anderluh PS, Prezelj A (2007a) Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis. Curr Pharm Des 13:2283-2309
12. Kotnik M, Humljan J, Contreras-Martel C, Oblak M, Kristan K, Herve M, Blanot D, Urleb U, Gobec S, Dessen A, Solmajer TJ (2007b) Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase. Mol Biol 370:107-115
13. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK—a program to check the stereochemical quality of protein structures. J Appl Cryst 26:283-291
14. Livermore DM (2003) Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36:S11-S23
15. Mahapatra S, Crick DC, Brennan PJ (2000) Comparison of the UDPN-acetylmuramate: L-alanine ligase enzymes from Mycobacterium tuberculosis and Mycobacterium leprae. J Bacteriol 182:6827-6830
16. Marmor S, Petersen CP, Reck F, Yang W, Gao N, Fisher SL (2001) Biochemical characterization of a phosphinate inhibitor of Escherichia coli MurC. Biochemistry 40:12207-12214
17. Miller DJ, Hammond SM, Anderluzzi D, Bugg TDH (1998) Aminoalkylphosphinate inhibitors of D-Ala-D-Ala adding enzyme. J Chem Soc Perkin 1:131-142
18. Morales AH, Perez MA, Combes RD, Gonzalez MP (2006) Quantitative structure activity relationship for the computational prediction of nitro compounds carcinogenicity. Toxicology 220:51-62
19. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785-2791
20. Reck F, Marmor S, Fisher S, Wuonola MA (2001) Inhibitors of the bacterial cell wall biosynthesis enzyme MurC. Bioorg Med Chem Lett 11:1451-1454
21. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815
22. Shanmugam A, Natarajan J (2010) Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification. Bioinformation 4:392-395
23. Shanmugam A, Natarajan J (2011) Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy J Mol Model. doi: 10.1007/s00894-011-1285-z) (in press)
24. Sova M, Cadez G, Turk S, Majce V, Polanc S, Batson S, Lloyd AJ, Roper DI, Fishwick CW, Gobec S (2009a) Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB). Bioorg Med Chem Lett 19:1376-1379
25. Sova M, Kovac A, Turk S, Hrast M, Blanot D, Gobec S (2009b) Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF. Bioorg Chem 37:217-222
26. Strancar K, Blanot D, Gobec S (2006) Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD. Bioorg Med Chem Lett 16:343-348
27. Strancar K, Boniface A, Blanot D, Gobec S (2007) Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-d-glutamate: L-lysine ligase (MurE). Arch Pharm (Weinheim) 340:127-134
28. Tanner ME, Vaganay S, van Heijenoort J, Blanot D (1996) Phosphinate inhibitors of the D-glutamic acid-adding enzyme of peptidoglycan biosynthesis. J Org Chem 61:1756-1760
29. Vollmer W, Blanot D, de Pedro MA (2008) Peptidoglycan structure and architecture. FEMS Microbiol Rev 32:149-167
30. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:D668-D672
31. Zeng B, Wong KK, Pompliano DL, Reddy S, Tanner ME (1998) A phosphinate inhibitor of the meso-diaminopimelic acid-adding enzyme (MurE) of peptidoglycan biosynthesis. J Org Chem 63:10081-10086